Bumper Offer - Urjas oil Just @ Rs. 1
Vepan 125 Rediuse Syrup, a prescription drug, is manufactured in various forms such as Syrup. Primarily, it is used for the treatment of Bacterial Infections, Tonsillitis, Throat Infection. Vepan 125 Rediuse Syrup also has some secondary and off-label uses. These are listed below.
The correct dosage of Vepan 125 Rediuse Syrup depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Vepan 125 Rediuse Syrup can also lead to other problems, which have been listed below. Such side effects of Vepan 125 Rediuse Syrup normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Vepan 125 Rediuse Syrup is Safe for pregnant women and Safe for women who are breastfeeding. It is important to know if Vepan 125 Rediuse Syrup has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Vepan 125 Rediuse Syrup related warnings section.
Other conditions have been mentioned below in the Vepan 125 Rediuse Syrup contraindications section.
Additionally, Vepan 125 Rediuse Syrup may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Vepan 125 Rediuse Syrup is not safe while driving, and is is not addictive in nature.
Vepan 125 Rediuse Syrup is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Vepan 125 Rediuse Syrup is used -
Severe
Mild
Is the use of Vepan 125 Rediuse Syrup safe for pregnant women?
Pregnant women can take Vepan safely.
Is the use of Vepan 125 Rediuse Syrup safe during breastfeeding?
Vepan is completely safe for breastfeeding women.
What is the effect of Vepan 125 Rediuse Syrup on the Kidneys?
Vepan rarely harms the kidneys.
What is the effect of Vepan 125 Rediuse Syrup on the Liver?
Vepan is not harmful for the liver.
What is the effect of Vepan 125 Rediuse Syrup on the Heart?
There are no any side effects of Vepan for the heart.
Vepan 125 Rediuse Syrup should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Vepan 125 Rediuse Syrup unless your doctor advises you to do so -
Is this Vepan 125 Rediuse Syrup habit forming or addictive?
No, you will not get addicted to Vepan 125 Rediuse Syrup.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Vepan 125 Rediuse Syrup. So it is best to avoid driving.
Is it safe?
Yes, but take Vepan 125 Rediuse Syrup only as per medical advice.
Is it able to treat mental disorders?
Vepan 125 Rediuse Syrup is unable to treat or cure mental disorders.
Interaction between Food and Vepan 125 Rediuse Syrup
You can take Vepan 125 Rediuse Syrup with food.
Interaction between Alcohol and Vepan 125 Rediuse Syrup
You may consume alcohol while taking Vepan 125 Rediuse Syrup. But caution is still important.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Duricef® (cefadroxil monohydrate)